...Phase Ib data for AK104 from Akeso Inc. (HKEX:9926). AMG509 is a bispecific mAb targeting STEAP1... ...OX40L (CD134L) - OX40 ligand PD-1 (PDCD1; CD279) - Programmed cell death 1 STEAP1 - Six-transmembrane epithelial antigen of prostate 1
Stephen...
Agensys received U.S. Patents Nos. 6,329,503 and 6,277,972. The ‘503 patent covers STEAP-1, which is a cell surface ion channel overexpressed in prostate cancer patients. Patent ‘972 covers BPC-1 and methods for producing the protein....
UroGenesys Inc. has developed a platform focused on finding proteins involved in urological diseases as fast as possible. In two years of work, the company has identified 40 proteins that meet strict criteria for differential...
UroGenesys researchers published in the Proceedings of the National Academy of Sciences the identification of STEAP as a protein expressed predominantly in human prostate tissue that is upregulated in multiple cancer cell lines. They suggested...
